| 1. |
Wang B, Ogata H, Takishima Y, Miyamoto S, Inoue H, Kuroda M, Yamada K, Hijikata Y, Murahashi M, Shimizu H, Okazaki T, Nakanishi Y, Tani K., A Novel Combination Therapy for Human Oxaliplatin-resistant Colorectal Cancer Using Oxaliplatin and Coxsackievirus A11., Anticancer Res. 2018;38(11):6121-6126., 2018.11. |
| 2. |
Hisanobu Ogata, Angiotensin II type I receptor blocker, Losartan, inhibits fibrosis in liver by suppressing TGF-beta1 production., Integr Mol Med, DOI: 10.15761/IMM.1000199., 2016.04. |
| 3. |
Hisanobu Ogata (Co-First author), Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling, CELL, 10.1016/j.cell.2013.09.031, 155, 2, 384-396, 2013.10. |
| 4. |
Hiroyuki Takahashi, Hisanobu Ogata, Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation., Cancer Cell, 2010.01. |
| 5. |
Hisanobu Ogata, Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis, GASTROENTEROLOGY, 10.1053/j.gastro.2006.04.025, 131, 1, 179-193, 2006.07. |
| 6. |
Hisanobu Ogata, Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta 1 production, ONCOGENE, 10.1038/sj.onc.1209281, 25, 17, 2520-2530, 2006.04. |
